Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Genomics and Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB
Last data update: Jan 24, 2021. (Total: 38387 Documents since 2012)
   dataset
Filtered By:
Records 1-30 (of 211 Record(s))
Query Trace: Sickle cell disease[original query]>>Translation/Implementation Studies[Product Type]
Publication
Association of sickle cell disease with anthropometric indices among under-five children: evidence from 2018 Nigeria Demographic and Health Survey.
Islam Mohammad Redwanul et al. BMC medicine 2021 Jan 19(1) 5
Distribution of haemoglobin genotypes, knowledge, attitude and practices towards sickle cell disease among unmarried youths in the Buea Health District, Cameroon.
Ngwengi Nini Yesih et al. The Pan African medical journal 2020 37109
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.
Tartaglione Immacolata et al. Blood cells, molecules & diseases 2021 Jan 88102531
[Results of the neonatal screening on Western Andalusia after a decade of experience.]
Delgado-Pecellín Carmen et al. Revista espanola de salud publica 2020 Dec 94
[50 years of the Neonatal Screening Program in Catalonia.]
Marín Soria Jose Luis et al. Revista espanola de salud publica 2020 Dec 94
Processing of positive newborn screening results: a qualitative exploration of current practice in England.
Chudleigh Jane et al. BMJ open 2020 Dec 10(12) e044755
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.
Esrick Erica B et al. The New England journal of medicine 2020 Dec
Surveillance for sickle cell disease, United Republic of Tanzania.
Ambrose Emmanuela E et al. Bulletin of the World Health Organization 2020 Dec 98(12) 859-868
Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Oluwole Esther O et al. PloS one 2020 15(12) e0242861
Attitudes and impact among people with abnormal premarital screening test results in Muscat governorate's primary healthcare centers in 2018.
Al Zeedi Manar Al Sanaa Ali et al. Journal of community genetics 2020 Nov
[Prevalence of sickle cell trait in blood donors at the regional blood transfusion center in the Haute Matsiatra Region, Madagascar].
Fenomanana Jocia et al. The Pan African medical journal 2020 36329
Trends in Sickle Cell Trait and Disease Screening in the Republic of Uganda, 2014-2019.
Hernandez Arielle G et al. Tropical medicine & international health : TM & IH 2020 Nov
Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial.
Yasara Nirmani et al. BMJ open 2020 Oct 10(10) e041958
Evaluation of Technical Issues in a Pilot Multicenter Newborn Screening Program for Sickle Cell Disease.
Martella Maddalena et al. International journal of neonatal screening 2019 Mar 5(1) 2
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform.
Naubourg Pierre et al. International journal of neonatal screening 2019 Mar 5(1) 10
Newborn Screening Long Term Follow-Up in the Medical Home.
Badawi Deborah et al. International journal of neonatal screening 2019 Sep 5(3) 25
Newborn Screening for Sickle Cell Disease: Indian Experience.
Colah Roshan B et al. International journal of neonatal screening 2018 Dec 4(4) 31
Utilising the 'Getting to Outcomes ® ' Framework in Community Engagement for Development and Implementation of Sickle Cell Disease Newborn Screening in Kaduna State, Nigeria.
Inusa Baba P D et al. International journal of neonatal screening 2018 Dec 4(4) 33
Neonatal Screening for Sickle Cell Disease in Belgium for More than 20 Years: An Experience for Comprehensive Care Improvement.
Gulbis Béatrice et al. International journal of neonatal screening 2018 Dec 4(4) 37
Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence.
Knight-Madden Jennifer et al. International journal of neonatal screening 2019 Mar 5(1) 5
The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD).
Silva-Pinto Ana C et al. International journal of neonatal screening 2019 Mar 5(1) 11
The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease.
Desine Stacy et al. AJOB empirical bioethics 2020 Oct 1-13
Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease.
Sinha Cynthia B et al. Pediatric blood & cancer 2020 Oct e28749
Effective Recruitment Strategies for a Sickle Cell Patient Registry Across Sites from the Sickle Cell Disease Implementation Consortium (SCDIC).
Masese Rita V et al. Journal of immigrant and minority health 2020 Oct
Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
Panepinto Julie A et al. Emerging infectious diseases 2020 26(10) 2473-2476
The Wide Spectrum of COVID-19 Clinical Presentation in Children.
Nathan Nadia et al. Journal of clinical medicine 2020 Sep 9(9)
Newborn Screening Practices and Alpha-Thalassemia Detection - United States, 2016.
Bender M A et al. MMWR. Morbidity and mortality weekly report 2020 Sep 69(36) 1269-1272
An Innovative Multilevel Test for Hemoglobinopathies: TGA/Chemometrics Simultaneously Identifies and Classifies Sickle Cell Disease From Thalassemia.
Risoluti Roberta et al. Frontiers in molecular biosciences 2020 7141
Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening.
Allaf Bichr et al. Clinical chemistry and laboratory medicine 2020 Aug
Extremely high birth prevalence of sickle cell disease in rural Tanzania.
Eastburg Luke et al. Pediatric blood & cancer 2020 Aug e28620
TOP